Drugs / RNA tumor vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05202561 | Mar 2022 → Jan 2023 | neoplasm | The First Affiliated Hospital of Bengbu Medical University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RNA tumor vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05202561 ↗ |
| Modality | Vaccine | “KRAS-targeted RNA vaccine injection” NCT05202561 ↗ |
| Route | Intramuscular | “Administration: intramuscular injection” NCT05202561 ↗ |
| Target | KRAS | “KRAS-targeted RNA vaccine injection” NCT05202561 ↗ |